Confusion Persists Over US Biosimilar Interchangeability

Urgent Need For Clarity Over Misperceptions Linked To Unique US Designation, Paper Insists

Vials Question Marks Confusion
The US interchangeability designation has led to confusion over biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products